{"id":"W4409344692","doi":"10.3389/or.2025.1564642","title":"Treating ER-positive breast cancer: a review of the current FDA-approved SERMs and SERDs and their mechanisms of action","year":2025,"lang":"en","type":"review","venue":"Oncology Reviews","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Medicine; Fulvestrant; Tamoxifen; Breast cancer; Raloxifene; Selective estrogen receptor modulator; Anastrozole; Estrogen receptor; Toremifene; Aromatase; Cancer; Oncology; Pharmacology; Exemestane; Internal medicine; Cancer research","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008102339,0.0005384196,0.005406543,0.0001049596,0.00007358089,0.00000370155,0.0001907768,0.0002293719,0.00004326183],"category_scores_gemma":[0.0001674021,0.0002771279,0.0006052368,0.0005228907,0.0002560592,0.00006016115,0.0001963191,0.0006173637,9.985301e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003777161,"about_ca_system_score_gemma":0.001015703,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0000287152,"about_ca_topic_score_gemma":0.00003568649,"domain_scores_codex":[0.9969476,0.0008657445,0.001312313,0.0005089805,0.0001358286,0.0002294925],"domain_scores_gemma":[0.996649,0.0003336648,0.002161331,0.0005661627,0.0002060587,0.00008378805],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00002346602,0.00005140229,0.000005797432,0.2974282,0.0001910915,5.538352e-7,0.00005741771,1.253352e-8,0.00002022097,0.00007180784,0.00008544044,0.7020646],"study_design_scores_gemma":[0.0002996812,0.0001109509,0.00002743334,0.3868058,0.002580607,0.0002791804,0.00001582206,9.868625e-7,0.00001767529,0.00008706216,0.6096547,0.000120078],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.000002167121,0.9934832,0.000210117,0.000667095,0.0003264979,0.004599889,0.0003314992,0.00001407681,0.0003654945],"genre_scores_gemma":[0.000003289432,0.9978094,0.0004131742,0.0004135754,0.0001147017,0.0009546059,0.00004281573,0.0000346964,0.0002138004],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.7019445,"threshold_uncertainty_score":0.9999681,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05362469868518655,"score_gpt":0.4212260659151388,"score_spread":0.3676013672299523,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}